Dr. Maryam Banikazemi, MD
NPI: 1831164672
Total Payments
$618,270
2024 Payments
$113,596
Companies
17
Transactions
694
Payment Breakdown by Category
Other$395,810 (64.0%)
Consulting$110,565 (17.9%)
Travel$97,323 (15.7%)
Food & Beverage$14,512 (2.3%)
Education$60.06 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $391,845 | 131 | 63.4% |
| Consulting Fee | $110,565 | 38 | 17.9% |
| Travel and Lodging | $97,323 | 249 | 15.7% |
| Food and Beverage | $14,512 | 267 | 2.3% |
| Honoraria | $3,965 | 5 | 0.6% |
| Education | $60.06 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $605,750 | 632 | $0 (2024) |
| Rhythm Pharmaceuticals, Inc. | $5,430 | 9 | $0 (2023) |
| Chiesi USA, Inc. | $3,673 | 6 | $0 (2024) |
| BioMarin Pharmaceutical Inc. | $954.00 | 18 | $0 (2024) |
| Gilead Sciences Inc | $680.00 | 1 | $0 (2017) |
| Millennium Pharmaceuticals, Inc. | $450.00 | 1 | $0 (2017) |
| Amicus Therapeutics, Inc. | $431.77 | 2 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $379.91 | 8 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $296.52 | 4 | $0 (2018) |
| Shire North American Group Inc | $62.02 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113,596 | 69 | GENZYME CORPORATION ($113,440) |
| 2023 | $80,897 | 95 | GENZYME CORPORATION ($80,396) |
| 2022 | $62,292 | 62 | GENZYME CORPORATION ($56,838) |
| 2021 | $30,345 | 28 | GENZYME CORPORATION ($27,427) |
| 2020 | $32,143 | 28 | GENZYME CORPORATION ($31,103) |
| 2019 | $89,687 | 119 | GENZYME CORPORATION ($89,088) |
| 2018 | $124,067 | 170 | GENZYME CORPORATION ($123,864) |
| 2017 | $85,242 | 123 | GENZYME CORPORATION ($83,594) |
All Payment Transactions
694 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,376.00 | General |
| Category: Genetic Disease | ||||||
| 12/04/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $477.83 | General |
| Category: Genetic Disease | ||||||
| 12/04/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $189.95 | General |
| Category: Genetic Disease | ||||||
| 10/29/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $47.82 | General |
| 10/24/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $112.55 | General |
| 10/23/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,560.00 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $347.50 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $95.23 | General |
| Category: Genetic Disease | ||||||
| 10/22/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,656.00 | General |
| Category: Genetic Disease | ||||||
| 10/22/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $737.22 | General |
| Category: Genetic Disease | ||||||
| 10/22/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $329.83 | General |
| Category: Genetic Disease | ||||||
| 10/22/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $118.67 | General |
| Category: Genetic Disease | ||||||
| 10/22/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $113.31 | General |
| Category: Genetic Disease | ||||||
| 10/09/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $67.64 | General |
| Category: Genetic Disease | ||||||
| 09/26/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,048.00 | General |
| 09/17/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,656.00 | General |
| Category: Genetic Disease | ||||||
| 09/17/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $765.92 | General |
| Category: Genetic Disease | ||||||
| 09/17/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $391.30 | General |
| Category: Genetic Disease | ||||||
| 09/17/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $257.60 | General |
| Category: Genetic Disease | ||||||
| 09/17/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $124.89 | General |
| Category: Genetic Disease | ||||||
| 08/23/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Food and Beverage | In-kind items and services | $92.15 | General |
| Category: Achondroplasia | ||||||
| 08/15/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,584.00 | General |
| Category: Genetic Disease | ||||||
| 08/15/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $120.29 | General |
| Category: Genetic Disease | ||||||
| 08/08/2024 | Chiesi USA, Inc. | ELFABRIO (Drug) | Food and Beverage | Cash or cash equivalent | $63.38 | General |
| Category: ERT FOR FABRY DISEASE | ||||||
| 07/30/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,072.00 | General |
| Category: Genetic Disease | ||||||
About Dr. Maryam Banikazemi, MD
Dr. Maryam Banikazemi, MD is a Medical Genetics, Ph.D. Medical Genetics healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831164672.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maryam Banikazemi, MD has received a total of $618,270 in payments from pharmaceutical and medical device companies, with $113,596 received in 2024. These payments were reported across 694 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($391,845).
Ad
Practice Information
- Specialty Medical Genetics, Ph.D. Medical Genetics
- Other Specialties Ph.D. Medical Genetics
- Location Valhalla, NY
- Active Since 02/22/2006
- Last Updated 03/08/2021
- Taxonomy Code 170100000X
- Entity Type Individual
- NPI Number 1831164672
Products in Payments
- FABRAZYME (Biological) $242,137
- FABRAZYME (Drug) $225,497
- CEREZYME (Drug) $36,443
- NO PRODUCT DISCUSSED (Drug) $17,070
- CERDELGA (Drug) $15,194
- LUMIZYME (Biological) $11,097
- LUMIZYME (Drug) $9,588
- XENPOZYME (Biological) $6,411
- Imcivree (Drug) $5,411
- NEXVIAZYME (Biological) $3,212
- FERRIPROX (Drug) $942.87
- FABRY-DISEASE (Drug) $282.76
- VOXZOGO 1.2mg (Biological) $244.72
- Brineura (Biological) $203.30
- Kanuma (Drug) $153.07
- Strensiq (Drug) $143.45
- Naglazyme (Biological) $135.79
- LAMZEDE (Drug) $104.33
- VOXZOGO 1.2mg (Drug) $92.15
- Vimizim (Biological) $90.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.